Scythian Biosciences Corporation TSXV: SCYB

Quote
Currency
Change
52WK Range
Volume
Market Cap
Quote
Currency
Change
52WK Range
Volume
Market Cap

InvestorIntel Features on Scythian Biosciences Corporation

Patent pending cannabinoid compounds bring new treatments to market


November 14, 2017
| November 14, 2017

Cannabinoids, the diverse compounds which bind to the homonymous receptors in the human body, are only recently being properly explored, […]


 

Scythian CEO on the potential impact of cannabinoid drugs on traumatic brain injuries


August 29, 2017
| August 29, 2017 | 1 Comment

Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with […]


Scythian to treat the secondary effects of traumatic brain injuries with cannabinoids


August 14, 2017
| August 14, 2017 | 3 Comments

Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]